Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Terns discloses new THRB agonists for NASH

March 10, 2020

Indian approval of saroglitazar for noncirrhotic NASH

March 6, 2020

Givlaari receives European approval for Givlaari treatment of AHP in adults and adolescents

March 4, 2020

FDA approves Pizensy for oral solution for chronic idiopathic constipation in adults

March 4, 2020

Dosing begins in phase I study of KAN-101 for the treatment of celiac disease

Feb. 28, 2020

FDA approves Barhemsys for prevention and treatment of PONV

Feb. 27, 2020

Gilead Sciences patents IRAK-4 inhibitors

Feb. 27, 2020

Defibrotide safe in young patients with sickle cell disease undergoing stem cell transplantation

Feb. 26, 2020

Pandion begins first-in-human trial of PT-101 for autoimmune disease

Feb. 26, 2020

Guangzhou Henovcom Bioscience identifies new NR1H4 agonists

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...